Stay updated with breaking news from Topline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Reported positive topline data from the completed Part A safety lead-in of the THIO-101 Phase 2 go-to-market trial in advanced Non-Small Cell Lung Cancer and commenced recruitment in Part B... | May 8, 2023
Announced positive topline data from the Phase 3 EMERGENT-3 trial of KarXT in schizophrenia in the first quarter of 2023 On track to submit New Drug Application for KarXT in schizophrenia with the... | May 4, 2023
Completed enrollment for Phase 2 SEQUEL trial in mild-to-moderate Alzheimer’s disease ; topline results expected 2Q 2023 SHINE trial currently enrolling patients with first patient in Spain... | May 4, 2023
Sustained Topline Growth, Expanding Margins TORONTO, May 04, 2023 -- Altus Group Limited , a leading provider of asset and fund intelligence for commercial real estate , announced today its... | May 4, 2023
EQS-Ad-hoc: Majorel Group Luxembourg S.A. / Key word(s): Quarter Results/Quarter Results Majorel Group Luxembourg S.A.: Majorel reports strong topline growth of +11% for Q1 2023 03-May-2023 / 08:00